Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Zai

Showing results (131-140 of 208) with videos related to

Pageof 21
Sort By:
Journal of Psychiatric Research|December 4, 2022
Association analyses of the autosomal genome and mitochondrial DNA with accelerometry-derived sleep parameters in depressed UK biobank subjectsLindsay M Melhuish Beaupre, Michael Wainberg, Clement C Zai, et al.
Journal of Psychiatric Research|January 6, 2018
Genetic testing as a supporting tool in prescribing psychiatric medication: Design and protocol of the IMPACT studyDeanna Herbert, Maria Neves-Pereira, Ruth Baidya, et al.
Pharmacogenomics|December 16, 2015
Preliminary evidence for association of genome-wide significant DRD2 schizophrenia risk variant with clozapine responseEric Huang, Malgorzata Maciukiewicz, Clement C Zai, et al.
Schizophrenia Research|March 14, 2009
MDR1 gene in tardive dyskinesia scale scores: comparison of strategies for quantitative trait haplotype analysisVincenzo De Luca, Renan P Souza, Emanuella Viggiano, et al.
The Pharmacogenomics Journal|January 27, 2011
Association study of cannabinoid receptor 1 (CNR1) gene in tardive dyskinesiaA K Tiwari, C C Zai, O Likhodi, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 27, 2020
Association between the -2548G/A polymorphism of the leptin gene and antipsychotic-induced weight gain: Analysis of the CATIE sample and meta-analysisKazunari Yoshida, Malgorzata Maciukiewicz, Clement C Zai, et al.
Schizophrenia Bulletin|December 29, 2015
Increased Nigral SLC6A3 Activity in Schizophrenia Patients: Findings From the Toronto-McLean CohortsJames L Kennedy, Nian Xiong, Jinlong Yu, et al.
Journal of Clinical Psychopharmacology|January 2, 2013
Association of a functional polymorphism in neuropeptide Y with antipsychotic-induced weight gain in schizophrenia patientsArun K Tiwari, Eva J Brandl, Caroline Weber, et al.
Human Psychopharmacology|June 29, 2018
Pharmacogenetic evaluation of a DISP1 gene variant in antidepressant treatment of obsessive-compulsive disorderAmanda J Lisoway, Gwyneth Zai, Arun K Tiwari, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 8, 2013
A hypothesis-driven association study of 28 nuclear-encoded mitochondrial genes with antipsychotic-induced weight gain in schizophreniaVanessa F Gonçalves, Clement C Zai, Arun K Tiwari, et al.
Pageof 21

Showing results (131-140 of 208) with videos related to

Sort By:
Pageof 21
Journal of Psychiatric Research|December 4, 2022
Association analyses of the autosomal genome and mitochondrial DNA with accelerometry-derived sleep parameters in depressed UK biobank subjectsLindsay M Melhuish Beaupre, Michael Wainberg, Clement C Zai, et al.
Journal of Psychiatric Research|January 6, 2018
Genetic testing as a supporting tool in prescribing psychiatric medication: Design and protocol of the IMPACT studyDeanna Herbert, Maria Neves-Pereira, Ruth Baidya, et al.
Pharmacogenomics|December 16, 2015
Preliminary evidence for association of genome-wide significant DRD2 schizophrenia risk variant with clozapine responseEric Huang, Malgorzata Maciukiewicz, Clement C Zai, et al.
Schizophrenia Research|March 14, 2009
MDR1 gene in tardive dyskinesia scale scores: comparison of strategies for quantitative trait haplotype analysisVincenzo De Luca, Renan P Souza, Emanuella Viggiano, et al.
The Pharmacogenomics Journal|January 27, 2011
Association study of cannabinoid receptor 1 (CNR1) gene in tardive dyskinesiaA K Tiwari, C C Zai, O Likhodi, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 27, 2020
Association between the -2548G/A polymorphism of the leptin gene and antipsychotic-induced weight gain: Analysis of the CATIE sample and meta-analysisKazunari Yoshida, Malgorzata Maciukiewicz, Clement C Zai, et al.
Schizophrenia Bulletin|December 29, 2015
Increased Nigral SLC6A3 Activity in Schizophrenia Patients: Findings From the Toronto-McLean CohortsJames L Kennedy, Nian Xiong, Jinlong Yu, et al.
Journal of Clinical Psychopharmacology|January 2, 2013
Association of a functional polymorphism in neuropeptide Y with antipsychotic-induced weight gain in schizophrenia patientsArun K Tiwari, Eva J Brandl, Caroline Weber, et al.
Human Psychopharmacology|June 29, 2018
Pharmacogenetic evaluation of a DISP1 gene variant in antidepressant treatment of obsessive-compulsive disorderAmanda J Lisoway, Gwyneth Zai, Arun K Tiwari, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 8, 2013
A hypothesis-driven association study of 28 nuclear-encoded mitochondrial genes with antipsychotic-induced weight gain in schizophreniaVanessa F Gonçalves, Clement C Zai, Arun K Tiwari, et al.
Pageof 21